Seminar by Prof. Reinhilde Veugelers, KU Leuven
Event details
| Date | 10.10.2017 |
| Hour | 13:00 › 14:30 |
| Speaker | Prof. Reinhilde Veugelers, KU Leuven |
| Location | |
| Category | Conferences - Seminars |
"The role of small firms, large firms and universities in the creation, development and commercialization of novel inventions in biotech"
Abstract Despite anecdotal evidence, literature does not provide a clear understanding of how the process of novel inventions unfolds. A capabilities-based view leads to a division of labour wherein large firms are more efficient at commercializing novelty, whereas small firms may either be creators of novelty, or intermediaries between universities and large firms. Using a new patent-based indicator for technology trajectories and novel data, we sketch a framework to study the role of different actor types in the generation of technological novelty, its follow-on development, and its commercial application. Key preliminary findings indicate an unambiguous relative advantage of small firms as novelty creators, and their important role as further developers, both internally of own novel inventions and as external reusers of university novelty. Large firms are less active reusers of particularly small firm novelty.
Abstract Despite anecdotal evidence, literature does not provide a clear understanding of how the process of novel inventions unfolds. A capabilities-based view leads to a division of labour wherein large firms are more efficient at commercializing novelty, whereas small firms may either be creators of novelty, or intermediaries between universities and large firms. Using a new patent-based indicator for technology trajectories and novel data, we sketch a framework to study the role of different actor types in the generation of technological novelty, its follow-on development, and its commercial application. Key preliminary findings indicate an unambiguous relative advantage of small firms as novelty creators, and their important role as further developers, both internally of own novel inventions and as external reusers of university novelty. Large firms are less active reusers of particularly small firm novelty.
Practical information
- General public
- Free